November 12th 2024
The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.
November 11th 2024
Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.
October 7th 2024
Less than one-quarter of people infected with influenza-associated severe acute respiratory illness were vaccinated, according to a new report.
September 30th 2024
Your daily dose of the clinical news you may have missed.
September 20th 2024
FluMist is the first influenza vaccine that does not have to be given by a health care professional.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 15, 2021
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 14, 2021
Flu Called out by COVID as "Irrelevant," Flu Calls Press Conference, Issues Statement
COVID-19, in an attempt to bully Flu and potentially gain precious lung space in humans this year, provoked the veteran virus, labeling him as "irrelevant." Flu responds.
Flu Responds to COVID-19 Allegations: Press Conference Transcript
Influenza takes questions from key media outlets to rebut assertions by COVID-19 that Flu's heyday has come to an end. He replies to MSNBC, Fox News, CBS, & the Christian Science Monitor.
FDA Extends Pfizer-BioNTech COVID-19 Vaccine Booster EUA to Cover 16-17-year-olds
Referencing waning immunity of the 2-dose mRNA series and availability of the vaccine to youth in this age group for more than a year, FDA determined that benefits outweigh risks.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 9, 2021
Pfizer: Protection Against Omicron Variant ‘Improved’ After 3 Doses of COVID-19 Vaccine
New preliminary laboratory data showed 3 doses of the Pfizer-BioNTech COVID-19 vaccine neutralized the Omicron variant while 2 doses reduced neutralization titers.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 8, 2021
Flu Takes Backseat to COVID-19: Survey of US Adults
Getting sick with COVID-19 is more worrisome to US adults than contracting the flu, the NFID found. How will that impact uptake of the flu shot this season?
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 7, 2021
J&J COVID-19 Booster May Offer More Protection in Mix-and-Match Scenario
A J&J booster shot following a 2-dose regimen of the Pfizer vaccine produced a greater CD8+ T-cell response than a third Pfizer dose, according to preliminary data.
Early Increase in Positive Flu Tests Seen Among Young Adults
Pockets of positive tests for influenza A(H3N2), including on college campuses, may herald the opening of the 2021-2022 flu season.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 2, 2021
NIH Influenza and COVID-19 Guideline Topline: Testing, Treatment, and Vaccination
The influenza and SARS-CoV-2 viruses once again are in cocirculation. Following is a topline look at the NIH guideline on their simultaneous management.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 1, 2021
FDA Advisory Committee Narrowly Backs Merck’s Oral COVID-19 Antiviral
The 13-10 vote was not without controversy as panel members discussed concerns over the novel antiviral's safety risks and modest efficacy.
Omicron Variant Update: Notes on Headline News 12-1-2021
The Omicron variant of COVID-19 was today identified for the first time in the US, according to the CDC. Get a topline look at other recent breaking news in this slide show.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 30, 2021
Omicron Variant is Moving Quickly but Much Remains Unknown, says WHO
The Omicron variant of the SARS-CoV-2 virus is spreading quickly, jumping continents with infected travelers. The best protection remains vaccination and indoor precautions.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 23, 2021
COVID-19 Cases, Hospitalizations Up: Top 5 States Reporting Increases
COVID-19 cases are up by double digits in many states and hospitalizations have made big leaps in others. We report the top 5 in each category for the 7 days from 11/14-21.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 22, 2021
FDA, CDC Authorize Use of Pfizer, Moderna Booster Shots for Every US Adult
Booster doses for US adults at least 18 years of age are expected to be available as soon as this weekend.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 19, 2021
COVID-19 Misinformation Still Rampant in US: Kaiser Family Foundation Findings
New survey finds 78% of US adults either believe or are unsure about at least 4 of 8 COVID-19 myths tested, with unvaccinated adults among the most likely to hold misconceptions.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 16, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 15, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 12, 2021
Study Finds COVID-19 Antibodies in Breast Milk of Vaccinated Mothers
Mothers vaccinated against COVID-19 produced robust IgG antibodies in breast milk that actively neutralized the SARS-CoV-2 virus, according to investigators.
Pfizer Submits Request to Expand COVID-19 Booster EUA to All US Adults
Pfizer-BioNTech included data in its FDA submission showing the 3rd mRNA shot restores protection against symptomatic COVDI-19 to about 95%.